Pages that link to "Q22241438"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics and Clinical Effectiveness of Methylphenidate (Q22241438):
Displaying 50 items.
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) (Q22061981) (← links)
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management (Q22252568) (← links)
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studies (Q24186221) (← links)
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (Q24193549) (← links)
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (Q26471999) (← links)
- A functional neuroimaging study of fusiform response to restricted interests in children and adolescents with autism spectrum disorder (Q27320182) (← links)
- Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices (Q28243881) (← links)
- Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children (Q28247448) (← links)
- Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates (Q28393582) (← links)
- Response of neural reward regions to food cues in autism spectrum disorders (Q30524779) (← links)
- A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD) (Q33463879) (← links)
- Catecholaminergic challenge uncovers distinct Pavlovian and instrumental mechanisms of motivated (in)action (Q33688413) (← links)
- Methylphenidate (OROS formulation). (Q33954270) (← links)
- Dexmethylphenidate (Q33961232) (← links)
- d-Methylphenidate is non-genotoxic in in vitro and in vivo assays (Q33965973) (← links)
- Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate (Q33976616) (← links)
- Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial (Q33988480) (← links)
- Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications (Q34109566) (← links)
- Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice (Q34217427) (← links)
- A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects (Q34293071) (← links)
- Wake-promoting pharmacotherapy for psychiatric disorders (Q34443394) (← links)
- Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder (Q34543502) (← links)
- Differences in Methylphenidate Dose Response between Periadolescent and Adult Rats in the Familiar Arena-Novel Alcove Task (Q34715697) (← links)
- A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder (Q34719188) (← links)
- Quantitative determination of d- and l-threo enantiomers of methylphenidate in brain tissue by liquid chromatography-mass spectrometry (Q34787453) (← links)
- Extended-release methylphenidate (Ritalin LA). (Q34967113) (← links)
- Stereo-specific LC and LC-MS bioassays of antidepressants and psychotics (Q35376254) (← links)
- Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin ® LA) in school children under daily practice conditions (Q35666257) (← links)
- Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline (Q36471058) (← links)
- Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder (Q36622139) (← links)
- Spotlight on methylphenidate controlled-delivery capsules (Equasym XL, Metadate CD) in the treatment of children and adolescents with attention-deficit hyperactivity disorder (Q36729625) (← links)
- Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management (Q37023974) (← links)
- Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder (Q37166164) (← links)
- Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells (Q37636405) (← links)
- Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage (Q37685508) (← links)
- Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants. (Q37700662) (← links)
- Drug metabolism in the horse: a review (Q37802313) (← links)
- Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder (Q37810900) (← links)
- Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents (Q37855780) (← links)
- Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain. (Q38038163) (← links)
- Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland (Q38061831) (← links)
- Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? (Q38156422) (← links)
- An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder (Q38214174) (← links)
- Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. (Q38243174) (← links)
- Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder (Q38901950) (← links)
- Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects (Q38903401) (← links)
- Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration (Q38907661) (← links)
- Effects of methylphenidate hydrochloride on the cardiovascular system in vivo and in vitro: a safety pharmacology study (Q39873788) (← links)
- Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial. (Q40140240) (← links)
- Pupil Size Tracks Attentional Performance In Attention-Deficit/Hyperactivity Disorder. (Q41419311) (← links)